SummaryThe supplier presents itself as a China-based OEM/ODM biotechnology and life-science manufacturing provider, covering recombinant protein expression, fermentation and scale-up, protein purification, and custom peptide synthesis from research through commercial supply. It reports quality assurance, raw-material traceability, documented corrective/preventive-action and complaint-handling procedures, and service quotations under FOB, EXW, CFR, and CIF terms. However, no certification evidence, customer cases, overseas agents or branches, overseas warehouses/showrooms, or in-stock capacity is provided. Financial records show zero values for the stated revenue and profitability indicators for the reported periods, which limits financial credibility assessment and may indicate unavailable or inactive reported operations. Its stated production and customization scope is broad, but some supporting operational evidence remains incomplete.
Supplier typeThe supplier is described as a China-based biotechnology, pharmaceutical, and life-science OEM/ODM manufacturer and technical-service provider. Its stated business scope also includes food additives, feed raw materials, cosmetics, and Class I and II medical devices, indicating a manufacturing and commercial supplier profile rather than a pure trading profile.
After-Sales capabilityThe supplier has a documented corrective and preventive action mechanism and a customer-complaint process, both reported as having followed records. However, it has no overseas agents or branches, no overseas warehouse or showroom, no in-stock capacity, and no stated overseas service countries, so its international after-sales coverage appears limited.
Production capacityThe supplier states that it supports laboratory, pilot, and large-scale manufacturing, including batch and fed-batch fermentation, scale-up, protein purification, peptide synthesis, and OEM supply. It reports average lead times within 15 workdays in both peak and off-season and identifies five qualified service-capability suppliers, supporting a stated production-service capability, although detailed facility capacity and validation records are not provided.
Customization capabilityCustomization is explicitly supported through OEM/ODM production, custom technical services, custom peptide synthesis, process design, gene cloning and vector construction, expression-system selection, process optimization, and flexible support from early development to commercial supply. This is direct evidence of broad customization across development and manufacturing stages.